Amy Rosenfeld regularly sends me papers and preprints, mostly on viruses but not always. Here they are for your enjoyment and education. When possible I link to PubMed, although sometimes at the time of posting a link is not available; and preprints are linked at either bioRxiv or medRxiv.

Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial (medRxiv)

Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study (Can Med Assoc J)

Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2 (bioRxiv)

Bulk IgG Glycosylation Predicts COVID-19 Severity and Vaccine Antibody Response (Cell Rep)

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals (J Infect)

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial (Nat Comm)

Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination (bioRxiv)

Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017 (Cell Rep)

Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design (Cell Rep Med)

Differential mosquito attraction to humans is associated with skin-derived carboxylic acid levels (Cell)

Pathogen spillover driven by rapid changes in bat ecology (Nature)

Retrotransposon activation during Drosophila metamorphosis conditions adult antiviral responses (Nat Genet)

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies (Cell Rep Med)

Functional proteomic profiling links deficient DNA clearance with increased mortality in individuals with severe COVID-19 pneumonia (Immunity)

CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques (Science)

Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design (Cell Rep Med)

Chlamydia repurposes the actin-binding protein EPS8 to disassemble epithelial tight junctions and promote infection (Cell Host Microbe)

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination (J Exp Med)

Selective retention of virus-specific tissue-resident T cells in healed skin after recovery from herpes zoster (Nat Comm)

Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission (Nat Micro)

Chances of finding COVID-virus ancestor ‘almost nil’, say virologists (Nature)

Associations between indoor relative humidity and global COVID-19 outcomes (J R Soc Interface)

The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants (medRxiv)

SARS-CoV-2 Genomic Diversity in Households Highlights the Challenges of Sequence-Based Transmission Inference (mSphere)

Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel (Nat Comm)

T follicular helper cells and the germinal centre are required for memory B cell formation and humoral immunity after ChAdOx1 nCoV-19 vaccination (Cell Rep Med)

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial (Nat Micro)

Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients (medRxiv)

Acute and postacute sequelae associated with SARS-CoV-2 reinfection (Nat Med)

Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations (Nat Micro)

Lifting Universal Masking in Schools – Covid-19 Incidence among Students and Staff (NEJM)

Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine (Cell Rep)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in macaques (Cell)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines (JACC)

Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19 (medRxiv)

Shared genetic influences between blood analyte levels and risk of severe COVID-19 (Cell Rep)

Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review (Heliyon)

Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum (Cell Discovery)

mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1 (bioRxiv)

Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum (Cell Discovery)

Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster (iScience)

Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex (NPJ Vaccines)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters (bioRxiv)

Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot (bioRxiv)

Sterilizing immunity: Understanding COVID-19 (Immunity)

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice (Nat Med)

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel (NEJM)

Heart risks, data gaps fuel debate over COVID-19 boosters for young people (Science)

The Pfizer COVID-19 vaccine doesn’t prevent transmission: Antivax disinformation goes viral again (Science Based Medicine)

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales (Lancet)

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection (Nat Med)

New vaccine to protect people in the EU and worldwide against dengue (European Medicines Agency)

Risk of Myocarditis and Pericarditis Following Coronavirus Disease 2019 Messenger RNA Vaccination—A Nationwide Study (medRxiv)

Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study (Lancet Glob Health)

Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study (Nat Comm)

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial (eBioMedicine)

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial (Nat Med)

Boosting with updated COVID-19 mRNA vaccines (Nat Med)

The neurobiology of long COVID (Neuron)

Seasonality of Common Human Coronaviruses, United States, 2014–2021 (Emerg Inf Dis)

A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines (Cell Rep Med)

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses (Cell Rep)

SARS-CoV-2 Omicron variant emerged under immune selection (Nat Micr)